Introduction of Candida auris Screening in a Simple Setup
Table of Contents
Candida auris Screening in a Simple Setup is possible to presumptively identify Candida auris in a simple laboratory setup, though definitive identification typically requires advanced methods. In resource-limited or basic clinical microbiology labs, we can still suspect or screen for Candida auris using a combination of culture characteristics, resistance patterns, and simple tests.

When to Suspect C. auris?
- Rapid-growing yeast in high-risk patients (ICU, cancer).
- Shows resistance to fluconazole.
- Doesn’t form germ tubes.
- Grows at 42°C and in 10% NaCl.
- Misidentified by automated systems.
Identification Methods In a Simple Setup
1. Growth on Chromogenic Media (e.g., CHROMagar Candida)
- Candida auris typically grows as pale pink to white colonies, but NOT green (like C. albicans), not metallic blue (like C. tropicalis).
- However, C. auris may resemble C. glabrata or C. haemulonii on chromogenic media, so this is presumptive only.
2. Salt and Temperature Tolerance
- C. auris can grow in:
- 10% NaCl (Halotolerant)
- 42°C incubation (Thermotolerant)
- Set up Sabouraud dextrose agar (SDA with NaCl and incubate at 42°C for 48 hours.
3. Antifungal Resistance Profile
- Test antifungal susceptibility using disc diffusion or MIC strips (if available).
- C. auris typically shows:
- Resistance to fluconazole (FLC)
- Variable resistance to amphotericin B and echinocandins
- If a Candida isolate shows multidrug resistance, suspect C. auris.
4. Colony Morphology on SDA
- Smooth, shiny, white-to-cream-colored colonies.
- Grows rapidly (24–48 hrs) at 37°C.
5. Gram Stain / Microscopy
- Oval yeast cells; no pseudohyphae or germ tubes.
- However, this is not sufficient alone for ID.
6. Sugar Assimilation (Optional)
- You may perform basic sugar assimilation tests (e.g., dextrose, galactose, maltose, lactose).
- C. auris is non-hemolytic, and its sugar assimilation profile differs from C. albicans.
What We CANNOT Do in Simple Labs:
- MALDI-TOF MS
- PCR or sequencing
- VITEK-2 without an updated database may misidentify it as C. haemulonii or C. famata
Confirmatory Identification
The isolate is sent to the reference lab for:
- MALDI-TOF MS (updated database)
- PCR targeting the ITS/D1-D2 region
- Whole-genome sequencing (if part of the outbreak)
Summary Table for Candida auris Screening
| Test | Result Suggestive of C. auris |
|---|---|
| Chromagar | Pale pink/white colonies |
| Germ tube | Negative |
| Growth at 42°C | Positive |
| Growth in 10% NaCl | Positive |
| Fluconazole resistance | Common |
| Germ tube | Absent |
| MALDI-TOF (if available) | Confirmatory |
Keynotes
- Emerging Multidrug-Resistant Yeast; Candida auris is a rapidly emerging fungal pathogen with resistance to multiple antifungals, including azoles, polyenes, and sometimes echinocandins.
- Difficult to Identify in Routine Labs-It is often misidentified as C. haemulonii, C. famata, or C. lusitaniae by conventional systems (e.g., VITEK-2 without updated database).
- Causes Invasive Infections: Common infections include candidemia, wound infections, and ventilator-associated pneumonia, especially in ICU and immunocompromised patients.
- High Mortality Rates: Mortality from C. auris bloodstream infection ranges from 30% to 60%, particularly in critically ill or cancer patients.
- Transmits Person-to-Person: Unlike other Candida species, C. auris spreads nosocomially (via healthcare contact, contaminated surfaces, or devices).
- Grows at High Temperature and Salinity: It can grow at 42°C and in 10% NaCl, helping distinguish it from other Candida species.
- No Germ Tube Formation: C. auris is germ tube negative and does not produce pseudohyphae, which helps rule out C. albicans.
- Forms Biofilms on Medical Devices: Adheres to catheters, ventilators, and hospital surfaces, making eradication and infection control challenging.
- Resistant to Fluconazole: >90% of isolates are resistant to fluconazole; some strains are pan-resistant to all major antifungal classes.
- Requires Contact Precautions and Outbreak Control: Identification mandates notification, isolation, surface disinfection, and public health alert due to outbreak potential.
Further Readings
- https://www.cdc.gov/candida-auris/index.html
- https://my.clevelandclinic.org/health/diseases/25152-candida-auris
- https://www.chp.gov.hk/en/healthtopics/content/24/106835.html
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8069182/
- https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/Candida-auris
- https://doh.wa.gov/public-health-provider-resources/notifiable-conditions/candida-auris
- https://www.gov.uk/government/collections/candidozyma-auris
- https://www.publichealthontario.ca/en/Diseases-and-Conditions/Health-Care-Associated-Infections/Candida-auris
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10495051/
- https://www.health.vic.gov.au/infectious-diseases/candida-auris-c-auris
- https://newsnetwork.mayoclinic.org/discussion/candida-auris-this-fungus-is-a-health-care-concern/
- https://www.nj.gov/health/cd/topics/cauris.shtml